1346576-38-2

Basic information

• Product Name: 1H-Indole-4-carboxylic acid, 6-broMo-3-forMyl-1-(1-Methylpropyl)-, Methyl ester
• Synonyms: 1H-Indole-4-carboxylic acid, 6-broMo-3-forMyl-1-(1-Methylpropyl)-, Methyl ester
• CAS NO: 1346576-38-2
• Molecular Formula: C15H16BrNO3
• Molecular Weight: 338.19644
• Mol File: 1346576-38-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1H-Indole-4-carboxylic acid, 6-broMo-3-forMyl-1-(1-Methylpropyl)-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indole-4-carboxylic acid, 6-broMo-3-forMyl-1-(1-Methylpropyl)-, Methyl ester(1346576-38-2)
• EPA Substance Registry System: 1H-Indole-4-carboxylic acid, 6-broMo-3-forMyl-1-(1-Methylpropyl)-, Methyl ester(1346576-38-2)

Safety Data

• Hazardous Substances Data: 1346576-38-2(Hazardous Substances Data)

Usage

General Description

1H-Indole-4-carboxylic acid, 6-bromo-3-formyl-1-(1-methylpropyl)-, methyl ester is a chemical compound with a complex and specific structure. It is a methyl ester of a derivative of indole-4-carboxylic acid, with a bromo and formyl group attached at specific positions, and a 1-methylpropyl substituent. 1H-Indole-4-carboxylic acid, 6-broMo-3-forMyl-1-(1-Methylpropyl)-, Methyl ester is of interest in pharmaceutical and chemical research due to its potential biological activity and role as a building block in the synthesis of various molecules. It may be used as a starting material or intermediate in the production of pharmaceuticals, agrochemicals, or other organic compounds with desired properties. Its unique structure and potential applications make it a valuable and versatile chemical compound in various industries.

Upstream product

• 107650-22-6 methyl 6-bromo-1-isopropyl-3-methyl-1H-indole-4-carboxylate 
• 220514-28-3 5-bromo-2-methyl-3-nitrobenzoic acid methyl ester 
• 1975-50-4 2-methyl-3-nitrobenzic acid 
• 107650-20-4 5-bromo-2-methyl-3-nitro-benzoic acid 

Downstream Products

• 1346576-39-3 methyl 6-bromo-1-(sec-butyl)-3-methyl-1H-indole-4-carboxylate 
• 1346574-61-5 6-{3-[(dimethylamino)methyl]phenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1R)-1-methylpropyl]-1H-indole-4-carboxamide 
• 1346574-60-4 6-{3-[(dimethylamino)methyl]phenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-1H-indole-4-carboxamide 
• 1346574-57-9 GSK-126 
• 1346574-55-7 (R)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide 
• 1346574-54-6 (S)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide 
• 1346574-59-1 6-{3-[(dimethylamino)methyl]phenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylpropyl)-1H-indole-4-carboxamide 
• 1346574-53-5 6-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylpropyl)-1H-indole-4-carboxamide 
• 1346575-54-9 6-bromo-1-(sec-butyl)-3-methyl-1H-indole-4-carboxylic acid 

Relevant articles and documents

SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

The present invention relates to substituted benzene compounds and bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

METHOD OF TREATMENT

The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.